Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

54.19
+0.86001.61%
Post-market: 54.14-0.0458-0.08%19:59 EST
Volume:40.40M
Turnover:2.19B
Market Cap:110.32B
PE:18.24
High:54.86
Open:53.41
Low:53.29
Close:53.33
52wk High:63.33
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:2.21
T/O Rate:1.99%
Dividend:2.48
Dividend Rate:4.58%
EPS(TTM):2.97
EPS(LYR):-4.4144
ROE:33.78%
ROA:9.39%
PB:5.95
PE(LYR):-12.28

Loading ...

HBM Holdings (SEHK:2142): Valuation Check After Bristol Myers Squibb Collaboration Validates Growth Prospects

Simply Wall St.
·
Dec 20

Merck (MRK.US), Bristol-Myers Squibb (BMY.US), and Other Pharma Giants Agree to Lower U.S. Drug Prices in Exchange for Tariff Exemptions and Policy Support

Stock News
·
Dec 20

Trump, Nine Pharmaceutical Companies Strike Deal to Cut Prices

Reuters
·
Dec 20

Shares of Some U.S. Drugmakers Rise After Signing Drug Pricing Deal With President Trump

THOMSON REUTERS
·
Dec 20

Shares of Bristol Myers Squibb up 1.8%, Gilead Sciences up 2.9%, Amgen and Merck up Nearly 1%

THOMSON REUTERS
·
Dec 20

BRIEF-Bristol Myers Squibb Announces Deal With U.S. Government

Reuters
·
Dec 20

Bristol Myers Squibb to Provide Eliquis Free to Medicaid Under U.S. Government Agreement

Reuters
·
Dec 20

Bristol Myers Squibb Announces Agreement With U.S. Government to Improve Affordability and Access to Critical Medicines for Americans

THOMSON REUTERS
·
Dec 20

Bristol-Myers Squibb Co: Medicines Available at Discounts About 80% off Current List Prices

THOMSON REUTERS
·
Dec 20

Bristol-Myers Squibb Co - Eliquis Free to Medicaid Starting January 1, 2026

THOMSON REUTERS
·
Dec 20

Bristol-Myers Squibb Co - Bms to Receive Three Years of Tariff Relief

THOMSON REUTERS
·
Dec 20

Bristol-Myers Squibb Co: Specific Terms of Agreement Remain Confidential

THOMSON REUTERS
·
Dec 20

Bristol Myers Squibb Says Its Donation to Strategic Reserve Will Include Top Selling Blood Thinner Eliquis

THOMSON REUTERS
·
Dec 20

Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies

MT Newswires Live
·
Dec 20

Trump: the 3 of the 17 Pharmaceutical Companies Who Have Not Agreed Are Coming in Next Week

THOMSON REUTERS
·
Dec 20

Several Manufacturers Agree to Donate Active Pharmaceutical Ingredients to U.S. Strategic Reserve -U.S. Official

THOMSON REUTERS
·
Dec 20

Companies Agree to Sell All Future Drugs at Most Favored Nation Prices -U.S. Official

THOMSON REUTERS
·
Dec 20

14 of 17 Leading Drug Manufacturers NOW Part of Trump Administration’s Most Favored Nation Initiative -U.S. Official

THOMSON REUTERS
·
Dec 20

Companies Will Offer Many Drugs Direct-to Consumer at Lower Prices Through Trumprx Website -U.S. Official

THOMSON REUTERS
·
Dec 20

Deals Are With Amgen, Bristol Myers Squibb, Roche’s Genentech, Gilead, GSK, Merck, Novartis, Sanofi and Boehringer Ingelheim -U.S. Official

THOMSON REUTERS
·
Dec 20